Kidney Disease Clinical Trials

Showing 321-340 of 3,902 trials

CArdio-Reno- Hepato -MEtabolic Disease iN Chronic Heart Failure (CARMEN-CHF)

NCT07380828

Study aims to investigate the incidence, associations and prognostic value of CRGM and its components: chronic kidney disease, type 2 diabetes, atherosclerotic cardiovascular diseases, and non-alcoholic fatty liver disease in patients with different phenotypes and severity of clinical manifestations of CHF.

Heart FailureCardio-renal-metabolic Syndrome

Russian Scientific Medical Society of Therapists3,000 participantsStarted Feb 2026

RECRUITINGNA

Laparoscopic Versus Robotic Lateral Transabdominal Adrenalectomy

NCT06407024

This study is being done to compare Laparoscopic vs Robotic lateral transabdominal adrenalectomy, these procedures are both standard of care. The study team would like to compare both patient outcomes and surgeon efficiency and perspectives among both procedures. The information from this study will help improve patient care, patient outcomes and maximize the appropriate utilization of resources in adrenal surgery.

Adrenalectomy

The Cleveland Clinic54 participantsStarted May 2024

Cleveland, Ohio, United States

RECRUITINGNA

Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients

NCT06978127

The goal of this study is to learn if a collaborative care intervention of pharmaco-therapy and/or cognitive behavioral therapy (CBT), delivered in a real-world setting, improves symptoms of pain, fatigue and/or depression.

Chronic Kidney Disease Requiring Hemodialysis

University of Pittsburgh424 participantsStarted Aug 2025

Albuquerque, New Mexico, United States • Pittsburgh, Pennsylvania, United States

CArdio-Reno- Hepato -MEtabolic Disease iN Chronic Heart Failure (CARMEN-CHF)

Laparoscopic Versus Robotic Lateral Transabdominal Adrenalectomy

Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients

Related Searches

Escitalopram and the Risk of Serious Adverse Events

Pivotal Study of the Velocity™ pAVF System

Medication Reconciliation in Hospitalized CKD Patients : A Quasi-Experimental Study

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade

Tubeless Spontaneous Ventilation Anesthesia in Kidney Transplantation

Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease

Phosphate Assessment in Chronic Kidney Disease Patients Study

Palliative Care Needs of Children With Rare Diseases and Their Families

Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)

Ketoanalogue Supplementation for Muscle Protection in CKD 4 and 5 Patients With Moderately Low Protein Diet (KETO-PROT-ACTION)

SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

Eye-Brain-Kidney in CKD

Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration